Trial Outcomes & Findings for TMS Enhancement of Visual Plasticity in Schizophrenia (NCT NCT03220438)

NCT ID: NCT03220438

Last Updated: 2025-04-18

Results Overview

fMRI BOLD response in visual cortex, during visual stimulation (0.9 Hz) before and after high frequency visual stimulation (9 Hz).

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

~1 hour

Results posted on

2025-04-18

Participant Flow

17 adults provided informed consent. 2 screen failures and 1 lost to follow-up before screening.

Participant milestones

Participant milestones
Measure
TMS (Active Then Sham)
Participants first received active rTMS 10Hz to the occipital cortex and then 2 weeks later received sham (A sham coil was used to control for the auditory artifacts induced by rTMS) TMS: Transcranial Magnetic Stimulation
TMS (Sham Then Active)
Participants first received sham (A sham coil was used to control for the auditory artifacts induced by rTMS) and then 2 weeks later received active rTMS 10Hz to the occipital cortex TMS: Transcranial Magnetic Stimulation
iTBS (Active Then Sham)
Participants first received active iTBS 5 Hz to the occipital cortex and then 2 weeks later received sham (a sham coil was used to control for the auditory artifacts induced by iTBS). Intermittent theta-burst stimulation: iTBS
iTBA (Sham Then Active)
Participants first received sham (a sham coil was used to control for the auditory artifacts induced by iTBS) and then 2 weeks later received active iTBS 5 Hz to the occipital cortex . Intermittent theta-burst stimulation: iTBS
Overall Study
STARTED
3
0
6
5
Overall Study
COMPLETED
3
0
5
5
Overall Study
NOT COMPLETED
0
0
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
TMS (Active Then Sham)
Participants first received active rTMS 10Hz to the occipital cortex and then 2 weeks later received sham (A sham coil was used to control for the auditory artifacts induced by rTMS) TMS: Transcranial Magnetic Stimulation
TMS (Sham Then Active)
Participants first received sham (A sham coil was used to control for the auditory artifacts induced by rTMS) and then 2 weeks later received active rTMS 10Hz to the occipital cortex TMS: Transcranial Magnetic Stimulation
iTBS (Active Then Sham)
Participants first received active iTBS 5 Hz to the occipital cortex and then 2 weeks later received sham (a sham coil was used to control for the auditory artifacts induced by iTBS). Intermittent theta-burst stimulation: iTBS
iTBA (Sham Then Active)
Participants first received sham (a sham coil was used to control for the auditory artifacts induced by iTBS) and then 2 weeks later received active iTBS 5 Hz to the occipital cortex . Intermittent theta-burst stimulation: iTBS
Overall Study
Lost to Follow-up
0
0
1
0

Baseline Characteristics

TMS Enhancement of Visual Plasticity in Schizophrenia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
TMS (Active Then Sham)
n=3 Participants
Participants first received active rTMS 10Hz to the occipital cortex and then 2 weeks later received sham (A sham coil was used to control for the auditory artifacts induced by rTMS)
TMS (Sham Then Active)
Participants first received sham (A sham coil was used to control for the auditory artifacts induced by rTMS) and then 2 weeks later received active rTMS 10Hz to the occipital cortex
iTBS (Active Then Sham)
n=6 Participants
Participants first received active iTBS 5 Hz to the occipital cortex and then 2 weeks later received sham (a sham coil was used to control for the auditory artifacts induced by iTBS).
iTBS (Sham Then Active)
n=5 Participants
Participants first received sham (a sham coil was used to control for the auditory artifacts induced by iTBS) and then 2 weeks later received active iTBS 5 Hz to the occipital cortex
Total
n=14 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
n=5 Participants
0 Participants
n=7 Participants
6 Participants
n=5 Participants
5 Participants
n=4 Participants
14 Participants
n=21 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Age, Continuous
33 years
STANDARD_DEVIATION 1 • n=5 Participants
32.5 years
STANDARD_DEVIATION 10.6 • n=5 Participants
33 years
STANDARD_DEVIATION 13.2 • n=4 Participants
32.77 years
STANDARD_DEVIATION 10.26 • n=21 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
2 Participants
n=5 Participants
2 Participants
n=4 Participants
4 Participants
n=21 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
4 Participants
n=5 Participants
3 Participants
n=4 Participants
10 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
1 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=5 Participants
6 Participants
n=5 Participants
5 Participants
n=4 Participants
13 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Race (NIH/OMB)
Asian
1 Participants
n=5 Participants
1 Participants
n=5 Participants
0 Participants
n=4 Participants
2 Participants
n=21 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
3 Participants
n=5 Participants
3 Participants
n=4 Participants
7 Participants
n=21 Participants
Race (NIH/OMB)
White
1 Participants
n=5 Participants
2 Participants
n=5 Participants
2 Participants
n=4 Participants
5 Participants
n=21 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Region of Enrollment
United States
3 participants
n=5 Participants
6 participants
n=5 Participants
5 participants
n=4 Participants
14 participants
n=21 Participants

PRIMARY outcome

Timeframe: ~1 hour

Population: 13 participants completed active and/or sham conditions for either TMS or iTBS

fMRI BOLD response in visual cortex, during visual stimulation (0.9 Hz) before and after high frequency visual stimulation (9 Hz).

Outcome measures

Outcome measures
Measure
Patient: Active TMS 10 Hz
n=1 Participants
rTMS 10Hz to the occipital cortex TMS: Transcranial Magnetic Stimulation
Patient: Sham TMS
n=1 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by rTMS. TMS: Transcranial Magnetic Stimulation
Patient: Active iTBS
n=7 Participants
iTBS 5 Hz to the occipital cortex Intermittent theta-burst stimulation: iTBS
Patient: Sham iTBS
n=6 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by iTBS Intermittent theta-burst stimulation: iTBS
Control: Active TMS 10 Hz
n=2 Participants
rTMS 10Hz to the occipital cortex Transcranial Magnetic Stimulation: Transcranial Magnetic Stimulation
Control: Sham TMS
n=2 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by rTMS. TMS: Transcranial Magnetic Stimulation
Control: Active iTBS
n=3 Participants
iTBS 5 Hz to the occipital cortex Intermittent theta-burst stimulation: iTBS
Control: Sham iTBS
n=3 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by iTBS Intermittent theta-burst stimulation: iTBS
fMRI Blood Oxygenation Level Dependent (BOLD) Response of Visual Plasticity
-2.95 Beta values
Standard Deviation 0
-0.66 Beta values
Standard Deviation 0
-0.29 Beta values
Standard Deviation 2.55
2.57 Beta values
Standard Deviation 4.17
-0.7 Beta values
Standard Deviation 4.33
0.86 Beta values
Standard Deviation 2.33
-2.44 Beta values
Standard Deviation 3.27
2.47 Beta values
Standard Deviation 1.36

SECONDARY outcome

Timeframe: ~1 hour

Population: 2 participants had missing data; 11 participants completed active and sham conditions for either TMS or iTBS

MRS was used to obtain occipital cortical glutamate levels (active, sham). Levels reflect institutional units, as is standard for the field.

Outcome measures

Outcome measures
Measure
Patient: Active TMS 10 Hz
n=1 Participants
rTMS 10Hz to the occipital cortex TMS: Transcranial Magnetic Stimulation
Patient: Sham TMS
n=1 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by rTMS. TMS: Transcranial Magnetic Stimulation
Patient: Active iTBS
n=7 Participants
iTBS 5 Hz to the occipital cortex Intermittent theta-burst stimulation: iTBS
Patient: Sham iTBS
n=7 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by iTBS Intermittent theta-burst stimulation: iTBS
Control: Active TMS 10 Hz
n=2 Participants
rTMS 10Hz to the occipital cortex Transcranial Magnetic Stimulation: Transcranial Magnetic Stimulation
Control: Sham TMS
n=2 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by rTMS. TMS: Transcranial Magnetic Stimulation
Control: Active iTBS
n=1 Participants
iTBS 5 Hz to the occipital cortex Intermittent theta-burst stimulation: iTBS
Control: Sham iTBS
n=1 Participants
A sham coil will be used. This condition controls for the auditory artifacts induced by iTBS Intermittent theta-burst stimulation: iTBS
Magnetic Resonance Spectroscopy (MRS) Assessment of Glutamate
8.96 spectroscopy institutional units
Standard Deviation NA
sd cannot be computed on 1 person
9.23 spectroscopy institutional units
Standard Deviation NA
sd cannot be computed on 1 person
9.34 spectroscopy institutional units
Standard Deviation 1.19
9.16 spectroscopy institutional units
Standard Deviation 1.15
10.61 spectroscopy institutional units
Standard Deviation 0.49
9.97 spectroscopy institutional units
Standard Deviation 0.07
12.04 spectroscopy institutional units
Standard Deviation NA
sd cannot be computed on 1 person
11.91 spectroscopy institutional units
Standard Deviation NA
sd cannot be computed on 1 person

Adverse Events

Active TMS 10 Hz

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham TMS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active iTBS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham iTBS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Laura Rowland

University of Maryland Baltimore

Phone: 410-402-6073

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place